Buscar resultados de ensayos clínicos
Dumping Syndrome - 10 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome Condición: Dumping Syndrome Fecha: 2012-05-09 Intervenciones: Drug: SOM230 Pasireotide (SOM230) sc injection was provided as solution for injection in individual 1-po |
Completed |
Nombre del estudio: SOMATULINE Autogel 90 mg IN DUMPING SYNDROME Condición: Dumping Syndrome Fecha: 2013-07-19 Intervenciones:
|
Completed |
Nombre del estudio: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome Condición: Postoperative Dumping Syndrome Fecha: 2013-07-01 Intervenciones:
|
Completed |
Nombre del estudio: Treatment of the Dumping Syndrome With Lanreotide Autogel® Condición: Dumping Syndrome Fecha: 2007-10-11 Intervenciones: Drug: Somatuline (Lanreotide Autogel®) |
Recruiting |
Nombre del estudio: Dumping Syndrome After Operation of Esophageal Atresia Type III Condición:
Fecha: 2015-08-14 Intervenciones: Biological: Oral Glucose 1.75g/kg of glucose is orally taken by the patient. Capillary glycemia is syste |
Recruiting |
Nombre del estudio: Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity Condición: Dumping Syndrome Fecha: 2016-09-01 Intervenciones: Behavioral: Dietary and nutritional recommendations conducted by a nurse Supplementary dietary and nutri |
Not yet recruiting |
Nombre del estudio: Gastrectomy, Eating Behaviour and GLP-1 Condición:
Fecha: 2016-11-17 Intervenciones:
|
Recruiting |
Nombre del estudio: Metabolic Consequences of Gastrointestinal Surgery Condición:
|
Recruiting |
Nombre del estudio: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Condición:
Intervenciones: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release |
Active, not recruiting |
Nombre del estudio: Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia Condición: Hyperinsulinemia Hypoglycemia Fecha: 2016-12-15 Intervenciones: Drug: Exendin (9-39) |